BR0308747A - Gordura que compreende uma mistura de triglicerìdeos, processo apropriado para preparação da gordura de triglicerìdeo, processo de preparação de espalhante em emulsão de água em óleo comestìvel e espalhante - Google Patents
Gordura que compreende uma mistura de triglicerìdeos, processo apropriado para preparação da gordura de triglicerìdeo, processo de preparação de espalhante em emulsão de água em óleo comestìvel e espalhanteInfo
- Publication number
- BR0308747A BR0308747A BR0308747-6A BR0308747A BR0308747A BR 0308747 A BR0308747 A BR 0308747A BR 0308747 A BR0308747 A BR 0308747A BR 0308747 A BR0308747 A BR 0308747A
- Authority
- BR
- Brazil
- Prior art keywords
- fat
- triglycerides
- acid residues
- fatty acid
- carbon atoms
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A23D7/001—Spread compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/555—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
- A61K47/557—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells the modifying agent being biotin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/66—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells
- A61K47/665—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells the pre-targeting system, clearing therapy or rescue therapy involving biotin-(strept) avidin systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6891—Pre-targeting systems involving an antibody for targeting specific cells
- A61K47/6897—Pre-targeting systems with two or three steps using antibody conjugates; Ligand-antiligand therapies
- A61K47/6898—Pre-targeting systems with two or three steps using antibody conjugates; Ligand-antiligand therapies using avidin- or biotin-conjugated antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
- C11C3/04—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
- C11C3/10—Ester interchange
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
- C12N15/877—Techniques for producing new mammalian cloned embryos
- C12N15/8775—Murine embryos
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0006—Modification of the membrane of cells, e.g. cell decoration
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0604—Whole embryos; Culture medium therefor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nanotechnology (AREA)
- Gynecology & Obstetrics (AREA)
- Biophysics (AREA)
- Reproductive Health (AREA)
- Medical Informatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Hematology (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
Abstract
"GORDURA QUE COMPREENDE UMA MISTURA DE TRIGLICERìDEOS, PROCESSO APROPRIADO PARA PREPARAçãO DA GORDURA DE TRIGLICERìDEO, PROCESSO DE PREPARAçãO DE ESPALHANTE EM EMULSãO DE áGUA EM óLEO COMESTìVEL E ESPALHANTE". Gordura apropriada como fase graxa para a fabricação de espalhantes com baixo teor de gordura que são estáveis sob temperaturas ambiente elevadas, em que a gordura compreende uma mistura de triglicerídeos, na qual 2,5 a 5,5% em peso dos triglicerídeos são HHH triglicerídeos, 25 a 65% em peso, preferencialmente 25 a 55% em peso dos HHH triglicerídeos são triiglicerídeos monoácidos e os HHH triglicerídeos restantes são compostos de resíduos de ácidos graxos misturados, 1,5 a 5% em peso dos triiglicerídeos são HHM e HMH triglicerídeos, pelo menos 85% em peso dos resíduos de ácidos graxos H em HHM e HMH são resíduos de ácido palmítico, em que H indica resíduos de ácidos graxos saturados que possuem comprimentos de cadeia de mais de quinze átomos de carbono e M indica resíduos de ácidos graxos saturados que possuem comprimentos de cadeia de doze ou quatorze átomos de carbono e em que o resíduo M é colocado no meio ou em uma das posições terminais. Essa fase graxa pode ser obtida através da incorporação em óleo de triglicerídeo de gordura A e gordura B em que a gordura A e a gordura B juntas representam de 6 a 15% em peso da gordura e a razão em peso A/B encontra-se na faixa de 1/9 a 4/6, caracterizada pelo fato de que, na gordura A, pelo menos 50% em peso dos triglicerídeos são completamente saturados, pelo menos 80% em peso dos resíduos de ácidos graxos saturados componentes possuem comprimento de cadeia de dezesseis átomos de carbono (P) ou dezoito átomos de carbono (S), em que a razão P:S encontra-se na faixa de 75:25 a 25:75, até 5% em peso dos resíduos de ácidos graxos saturados possuem comprimento de cadeia de doze ou quatorze átomos de carbono e, na gordura B, pelo menos 20% em peso, preferencialmente pelo menos 25% em peso dos triglicerídeos consistem de HHM e HMH triglicerídeos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02076376 | 2002-04-09 | ||
PCT/EP2003/002625 WO2003084337A1 (en) | 2002-04-09 | 2003-03-10 | Triglyceride fat |
Publications (2)
Publication Number | Publication Date |
---|---|
BR0308747A true BR0308747A (pt) | 2005-01-11 |
BR0308747B1 BR0308747B1 (pt) | 2013-12-17 |
Family
ID=28685931
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0308747-6B1A BR0308747B1 (pt) | 2002-04-09 | 2003-03-10 | Gordura, seu processo de preparação, processo para a preparação de espalhante e espalhante |
Country Status (12)
Country | Link |
---|---|
US (1) | US7524524B2 (pt) |
EP (1) | EP1492410B1 (pt) |
AT (1) | ATE457649T1 (pt) |
AU (1) | AU2003218752B2 (pt) |
BR (1) | BR0308747B1 (pt) |
CA (1) | CA2481700C (pt) |
DE (1) | DE60331298D1 (pt) |
MX (1) | MXPA04009732A (pt) |
PL (1) | PL205287B1 (pt) |
RU (1) | RU2307517C2 (pt) |
WO (1) | WO2003084337A1 (pt) |
ZA (1) | ZA200407149B (pt) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6388113B1 (en) | 1999-06-04 | 2002-05-14 | Consejo Superior De Investigaciones Cientificas ( Csic) | High oleic/high stearic sunflower oils |
DE60336072D1 (de) | 2002-08-12 | 2011-03-31 | Unilever Nv | Triglyzeridfett |
EP1651338B1 (en) | 2003-07-17 | 2011-05-18 | Unilever N.V. | Process for the preparation of an edible dispersion comprising oil and structuring agent |
GB0409156D0 (en) * | 2004-04-24 | 2004-05-26 | Haye Pierre | A procedure to manufacture a texturized, thermo-resistant and thermo-irreversible gel composed of vegetable and/or animal fats and the product made with this |
WO2006079445A1 (en) * | 2005-01-28 | 2006-08-03 | Unilever N.V. | Edible dispersions comprising oil and structuring agent |
CA2598401C (en) | 2005-02-17 | 2013-10-29 | Unilever Plc | Process for the preparation of a spreadable dispersion |
CA2620716C (en) | 2005-09-26 | 2013-07-23 | Unilever Plc | Non-hydrogenated hardstock fat |
US8431177B2 (en) * | 2007-08-02 | 2013-04-30 | Bunge Oils, Inc. | Shortenings and methods of making and using thereof |
WO2009087432A1 (es) * | 2008-01-10 | 2009-07-16 | Aceites Y Grasas Vegetales S.A. - Acegrasas S.A.. | Producto graso solido con bajo contenido de grasa saturada y libre de acidos grasos trans |
EP3178328B1 (en) * | 2008-06-11 | 2019-02-20 | General Mills Marketing, Inc. | Hydrated fat piece compositions and dough articles made therefrom |
EP2367435A1 (en) * | 2008-12-19 | 2011-09-28 | Unilever NV | Edible fat powders |
BRPI0916502B1 (pt) | 2008-12-19 | 2017-09-12 | Unilever N.V. | "edible fat powder and method for the preparation of a continuous fat paste" |
US9924730B2 (en) | 2010-06-22 | 2018-03-27 | Unilever Bcs Us, Inc. | Edible fat powders |
EP2651234B1 (en) | 2010-12-17 | 2015-01-21 | Unilever N.V. | Process of compacting a microporous fat powder and compacted fat powder so obtained |
US8993035B2 (en) | 2010-12-17 | 2015-03-31 | Conopco, Inc. | Edible water in oil emulsion |
WO2012154413A1 (en) | 2011-05-09 | 2012-11-15 | General Mills, Inc. | Fat compositions and related methods, including shortening particles and shortening compositions without added non-interesterified hardstock fat, and related products |
KR101831924B1 (ko) * | 2011-05-17 | 2018-02-26 | 닛신 오일리오그룹 가부시키가이샤 | 노 템퍼링형 하드 버터로서 사용가능한 유지 조성물 |
EP2840899B1 (en) | 2012-04-27 | 2016-09-14 | General Mills, Inc. | Fat particle compositions containing salt, dough and baked dough articles made therefrom, and related methods |
EP2692238A1 (en) * | 2012-08-03 | 2014-02-05 | Bunge Növényolajipari Zártköruen Muködo Részvénytársasag | New fat blend composition |
JP2018508222A (ja) | 2015-03-18 | 2018-03-29 | カーギル インコーポレイテッド | 低脂肪油中水エマルション |
CN111378534B (zh) * | 2018-12-27 | 2022-11-25 | 丰益(上海)生物技术研发中心有限公司 | 结构酯组合物及其制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1107206A (en) | 1964-12-28 | 1968-03-27 | Nat Biscuit Co | Hard butter and chocolate coating composition containing same |
DE3360419D1 (en) | 1982-03-12 | 1985-08-29 | Unilever Nv | Margarine fat blend, and a process for producing said fat blend |
GB8432058D0 (en) * | 1984-12-19 | 1985-01-30 | Unilever Plc | Edible fat |
DE69103845T2 (de) | 1990-08-02 | 1995-02-02 | Unilever Nv | Verbesserung essbarer Fette. |
ES2072085T3 (es) | 1991-07-03 | 1995-07-01 | Unilever Nv | Composiciones de chocolate mejoradas. |
US5470598A (en) * | 1994-03-23 | 1995-11-28 | The Procter & Gamble Company | Beta-prime stable low-saturate, low trans, all purpose shortening |
US6238926B1 (en) * | 1997-09-17 | 2001-05-29 | Cargilll, Incorporated | Partial interesterification of triacylglycerols |
GB2350618A (en) * | 1999-06-01 | 2000-12-06 | Danisco | Shortening systems comprising a non-hydrogenated vegetable oil and either a stearine fraction or a saturated fatty acid diglyceride |
-
2003
- 2003-03-10 AT AT03712001T patent/ATE457649T1/de not_active IP Right Cessation
- 2003-03-10 WO PCT/EP2003/002625 patent/WO2003084337A1/en not_active Application Discontinuation
- 2003-03-10 BR BRPI0308747-6B1A patent/BR0308747B1/pt not_active IP Right Cessation
- 2003-03-10 RU RU2004132825/13A patent/RU2307517C2/ru not_active IP Right Cessation
- 2003-03-10 EP EP03712001A patent/EP1492410B1/en not_active Expired - Lifetime
- 2003-03-10 MX MXPA04009732A patent/MXPA04009732A/es not_active Application Discontinuation
- 2003-03-10 AU AU2003218752A patent/AU2003218752B2/en not_active Ceased
- 2003-03-10 DE DE60331298T patent/DE60331298D1/de not_active Expired - Lifetime
- 2003-03-10 CA CA2481700A patent/CA2481700C/en not_active Expired - Lifetime
- 2003-03-10 PL PL371725A patent/PL205287B1/pl unknown
- 2003-03-10 US US10/510,380 patent/US7524524B2/en active Active
-
2004
- 2004-09-07 ZA ZA200407149A patent/ZA200407149B/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2003084337A1 (en) | 2003-10-16 |
ATE457649T1 (de) | 2010-03-15 |
PL205287B1 (pl) | 2010-03-31 |
RU2307517C2 (ru) | 2007-10-10 |
AU2003218752A1 (en) | 2003-10-20 |
AU2003218752B2 (en) | 2006-12-07 |
BR0308747B1 (pt) | 2013-12-17 |
CA2481700A1 (en) | 2003-10-16 |
DE60331298D1 (de) | 2010-04-01 |
ZA200407149B (en) | 2006-02-22 |
RU2004132825A (ru) | 2005-06-10 |
CA2481700C (en) | 2012-10-09 |
EP1492410A1 (en) | 2005-01-05 |
MXPA04009732A (es) | 2005-01-11 |
EP1492410B1 (en) | 2010-02-17 |
US20050220965A1 (en) | 2005-10-06 |
PL371725A1 (en) | 2005-06-27 |
US7524524B2 (en) | 2009-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0308747A (pt) | Gordura que compreende uma mistura de triglicerìdeos, processo apropriado para preparação da gordura de triglicerìdeo, processo de preparação de espalhante em emulsão de água em óleo comestìvel e espalhante | |
ATE551908T1 (de) | Triglyceridfett | |
DK1290119T3 (da) | Fremstilling af en blanding af triglycerider | |
WO2009008410A1 (ja) | 可塑性油脂組成物 | |
BR0115673B1 (pt) | emulsão espalhável comestível e processo de preparação de uma emulsão de água em óleo comestível espalhável | |
CO4650021A1 (es) | Amalgama grasa para margarina y esparcidos w/o cual puede utilizarse como margarina y en esparcidos, la amalgama grasa y la grasa de margarina y el producto graso asi obtenidos | |
DK1682226T3 (da) | Lipidpræparat til forbedring af mineralabsorption | |
BRPI0416403A (pt) | composição de óleo enriquecida em diglicerìdeo com ácido linoléico conjugado | |
CN100526445C (zh) | 含有长链高度不饱和脂肪酸的抗氧脂肪或油组合物 | |
BRPI0517130A (pt) | confeito aerado congelado | |
DK0455278T3 (da) | Spiselige fedtstoffer | |
WO2007078311A3 (en) | Non-hydrogenated vegetable oil based margarine | |
CA2495785A1 (en) | Triglyceride fat | |
HUP0402214A2 (hu) | Önthető zsírdiszperziók | |
EA200201217A1 (ru) | Состав для уменьшения гидравлического сопротивления | |
BR0202991A (pt) | Composição de ésteres de esterol-ácido graxo e alimentos contendo a mesma | |
ATE532413T1 (de) | Fett auf basis nicht-hydrogenierten pflanzenöls mithilfe einer erhöhten diglycerin-emulgatoren- zusammensetzungtt | |
WO2004108871A3 (fr) | Compositions liquides a base d'huile de colza oleique modifiee, utiles a titre de liquides isolants et caloporteurs, et dispositifs electriques les contenant | |
CA2376104A1 (en) | Water-in-oil type emulsified fat and/or oil composition | |
RU2004128937A (ru) | Жир с высоким содержанием триглицеридов, пригодный для производства спредов | |
IES940672A2 (en) | "An edible fat blend" | |
RU2137820C1 (ru) | Пищевой антиоксидант | |
GB2427198A (en) | Cooking oil containing camelina oil | |
BG109677A (bg) | Етерични свещи с лечебен ефект | |
RO122916B8 (ro) | Compoziţie de ungere pentru piei naturale |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 17/12/2013, OBSERVADAS AS CONDICOES LEGAIS. |
|
B25A | Requested transfer of rights approved | ||
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 19A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2661 DE 04-01-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |